Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent <i>Clostridioides difficile</i> Infection

Recurrent <i>Clostridioides difficile</i> infections (rCDI) have a substantial impact on healthcare systems, with limited and often expensive therapeutic options. Nonalcoholic fatty liver disease (NAFLD) affects about 25% of the adult population and is associated with metabolic syndrome, changes in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lara Šamadan, Mia Jeličić, Adriana Vince, Neven Papić
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-06-01
Col·lecció:	Antibiotics
Matèries:	<i>Clostridioides difficile</i> associated disease CDI nonalcoholic fatty liver disease NAFLD NASH recurrent disease
Accés en línia:	https://www.mdpi.com/2079-6382/10/7/780
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!